英文名称:HT-29
货号:GCL-0118
价格: ¥1600.00 ¥1600.00
产品详情
产品信息
物种 | Human |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
冻存条件 |
冻存液:55% 基础培养基+40% FBS+5% DMSO 温度:液氮 |
培养方案A(默认) |
生长培养基:McCoy's 5A[GPM150710]+10% FBS[163210]+1% P/S[GPB180120] 培养条件: 温度:37℃ |
推荐传代比例 | 1:3-1:6 |
推荐换液频率 | 2-3次/周 |
参考资料(来源文献)
背景描述 | HT-29细胞是由J·Fogh在1964年用移植培养方法和含15%FBS的F12培养液从原发性肿瘤分离的;近来,已建株的培养细胞用含相同血清McCoy's 5A培液培养。HT-29细胞在裸鼠中致瘤,也能在类固醇处理的地鼠中致瘤。HT-29细胞合成IgA、CEA、蛋白绑定TGF-β的分泌成分和粘液素等。 |
年龄(性别) | 44Y |
组织来源 | 结直肠腺癌 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 肠癌细胞 |
生物安全等级 | BSL-1 |
基因表达情况 | secretory component of IgA; carcinoembryonic antigen (CEA); transforming growth factor beta binding protein; mucin, myc+; ras+; myb+; fos+; sis+; p53+; abl -; ros -; src -, Blood Type A; Rh+; HLA A1, A3, B12, B17, Cw5, HT-29 cells are negative for CD4, but there is cell surface expression of galactose ceramide (a possible alternative receptor for HIV). |
致瘤性 | Yes, in nude mice; forms well differentiated adenocarcinoma consistent with colonic primary (grade I); tumors also form in steroid treated hamsters. |
受体表达情况 | human adrenergic alpha2A, urokinase receptor (u-PAR), vitamin D (moderate expression), urokinase receptor (u-PAR); vitamin D (moderate expression), human adrenergic alpha2A |
保藏机构 | ATCC; HTB-38 BCRJ; 0111 CCLV; CCLV-RIE 0960 DSMZ; ACC-299 ECACC; 91072201 |
相关文献
-
期刊:PHYTOCHEMISTRY
DOI:10.1016/j.phytochem.2024.114072
影响因子:3.8
相关产品: RKO Cells Line, HT-29 Cells Line
-
期刊:Scientific Reports
DOI:10.1038/s41598-024-76155-w
影响因子:3.8
相关产品: TUNEL In Situ (FITC), Annexin V-PE/7-AAD, CT26.WT Cells Line, HCT 116 Cells Line, HT-29 Cells Line
-
期刊:Scientific Reports
DOI:10.1038/s41598-024-62753-1
影响因子:3.8
相关产品: ECV-304 Cells Line, HT-29 Cells Line, HCT 116 Cells Line
-
期刊:Scientific Reports
DOI:10.1038/s41598-024-78202-y
影响因子:3.8
相关产品: HT-29 Cells Line
-
YOLO and residual network for colorectal cancer cell detection and counting(2024)
期刊:Heliyon
DOI:10.1016/j.heliyon.2024.e24403
影响因子:3.4
相关产品: HT-29 Cells Line
-
DDX18 influences chemotherapy sensitivity in colorectal cancer by regulating genomic stability(2024)
期刊:EXPERIMENTAL CELL RESEARCH
DOI:10.1016/j.yexcr.2024.114344
影响因子:3.3
相关产品: SW620(DMEM Cells Line, SW480 [SW-480] Cells Line, RKO Cells Line, HCT 116 Cells Line, HT-29 Cells Line
-
期刊:INTEGRATIVE CANCER THERAPIES
影响因子:2.9
相关产品: HT-29 Cells Line, HCT 116 Cells Line, SW480 [SW-480] Cells Line
-
期刊:CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
影响因子:2.9
-
期刊:TISSUE & CELL
DOI:10.1016/j.tice.2024.102702
影响因子:2.7
相关产品: LoVo Cells Line, SW480 [SW-480] Cells Line, HT-29 Cells Line, HCT 116 Cells Line, NCM460 Cells Line
-
期刊:PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
DOI:10.1080/10837450.2024.2312851
影响因子:2.6